* The Mexican senate’s finance & public credit committee has approved an opinion on the agriculture and intellectual property agreements drafted in US-Mexico-Canada Agreement (USMCA) regional trade deal that is currently in the process of being ratified by Mexico's legislature. The committee expressed concern that the new intellectual property rules will affect the price of biotechnological medicines, which comprise 79% of Mexican public health sector purchases. It could also present an obstacle to the entry of new bio-comparable medicines into the market. The committee also raised concerns that small farmers would not be able to compete against US farmers, who receive significantly larger subsidies from their government.
End of preview - This article contains approximately 107 words.
Subscribers: Log in now to read the full article
Not a Subscriber?
Choose from one of the following options